HAPPY NEW YEAR!!

KVK will begin manufacturing Diethylpropion 25mg tables by the middle of January 2011. This tablet will be almost identical in size, shape and color to the Watson brand. The KVK Diethylpropion 25mg will also be available in bottles of 100 tablets and will be less expensive than the Watson brand. KVK should have the Diethylpropion 75mg available by the third quarter of 2011. Please call our office for pricing information on the 25mg tablets.

On January 31, 2011 the FDA will vote on the approval of the new weight loss medication, Contrave. Contrave combines the alcohol and drug addiction medication, Naltrexone, with the antidepressant, Bupropion. The outside experts (FDA Panel) voted 13-7 to back the approval of Contrave but urged the FDA to require the company to conduct a larger clinical study to look at potential heart risks over time. Meridia was recently withdrawn from the market due to heart risks.